The abstract is read at the publisher; the summary is JClub's.
Across 117 non-randomised comparative effectiveness studies of invasive mould infections (2003–2024), 112 (96%) had at least one timepoint misalignment, creating widespread bias risk.
- Why it matters: Treatment guidance for invasive mould infections often depends on non-randomised evidence, which can yield biased effect estimates due to design and analytical weaknesses.
- What they did: The review assessed eligibility-treatment-follow-up alignment and confounding adjustment across aspergillosis, mucormycosis, fusariosis, scedosporiosis, lomentosporiosis, and phaeohyphomycosis, finding 140 evaluable CER questions.
- The result: Among those questions, 116 (83%) were susceptible to immortal time bias, 47 (34%) to post-baseline selection bias, and only one study avoided timepoint misalignment while handling confounding without post-baseline variables.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.